reports
Sustainability Weekly 27 – 31 May 2024
Last week, we published a flash on the results and prospects of the Green Deal and the Sustainable Finance Action Plan, in the run-up to the European elections, as well as a flash on the reasons for our upgrade to Best-in-class of ASML. All the resolutions supported by TotalEnergies' Board of Directors were approved at the AGM. VW confirmed its plans for a new BEV car by 2027 and said it would develop it alone. According to the IEA, accelerating the shift to clean energy technol...
Boubyan Bank: 1 director
A director at Boubyan Bank bought 611,698 shares at 0.579KWD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
EQS-News: STS Group AG continues positive development with significant...
EQS-News: STS Group AG / Key word(s): Quarter Results STS Group AG continues positive development with significant increase in sales revenue and earnings in the first quarter of 2024 03.06.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. STS Group AG continues positive development with significant increase in sales revenue and earnings in the first quarter of 2024 All segments contribute to growth despite economic headwinds Sales revenue increased by 9.4% to EUR 80.9 million (3M/2023: EUR 74.0 million) EBITDA almost doubled...
EQS-News: STS Group AG setzt positive Entwicklung mit deutlicher Umsat...
EQS-News: STS Group AG / Schlagwort(e): Quartalsergebnis STS Group AG setzt positive Entwicklung mit deutlicher Umsatz- und Ergebnissteigerung im ersten Quartal 2024 fort 03.06.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. STS Group AG setzt positive Entwicklung mit deutlicher Umsatz- und Ergebnissteigerung im ersten Quartal 2024 fort Alle Segmente tragen trotz konjunkturellem Gegenwind zum Wachstum bei Umsatz steigt um 9,4 % auf 80,9 Mio. EUR (3M/2023: 74,0 Mio. EUR) EBITDA auf 5,5 Mio. EUR nahezu verdoppelt (3M/20...
EQS-News: Mutares has successfully completed the acquisition of FSL La...
EQS-News: Mutares SE & Co. KGaA / Key word(s): Investment/Takeover Mutares has successfully completed the acquisition of FSL Ladenbau GmbH 03.06.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Mutares has successfully completed the acquisition of FSL Ladenbau GmbH Leading shopfitting provider with strong presence in Northern Germany Add-on acquisition to strengthen the Ganter Group with synergies within the range of customers and supply chain Revenues of approx. EUR 15 million planned in 2024 Munich, June 3, 2024 – Mutares...
Mitarbeitende der Glarner Kantonalbank unterstützen Rotes Kreuz Kanton...
Glarner Kantonalbank AG / Schlagwort(e): Sonstiges Mitarbeitende der Glarner Kantonalbank unterstützen Rotes Kreuz Kanton Glarus 03.06.2024 / 07:30 CET/CEST Glarus, 3. Juni 2024 – Sieben Mitarbeitende der Glarner Kantonalbank tauschten Büro gegen Handarbeit und unterstützten das Schweizerische Rote Kreuz Kanton Glarus im Rahmen eines Freiwilligentages beim Projekt «2x Weihnachten». Auch dieses Jahr konnte das Schweizerische Rote Kreuz des Kantons Glarus mithilfe des siebenköpfigen Teams der Glarner Kantonalbank das Projekt «2x Weihnachten» erfolgreich durchführen. Mit der ...
EQS-News: Mutares hat die Übernahme der FSL Ladenbau GmbH erfolgreich ...
EQS-News: Mutares SE & Co. KGaA / Schlagwort(e): Beteiligung/Unternehmensbeteiligung/Firmenübernahme Mutares hat die Übernahme der FSL Ladenbau GmbH erfolgreich abgeschlossen 03.06.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Mutares hat die Übernahme der FSL Ladenbau GmbH erfolgreich abgeschlossen Führender Ladenbauanbieter mit starker Präsenz in Norddeutschland Add-on-Akquisition zur Stärkung der Ganter Group mit Synergien im Bereich der Kunden und der Supply Chain Umsatz von ca. EUR 15 Mio. im Jahr 2024 geplant M...
Sustainability Weekly 27 – 31 Mai 2023
La semaine passée, nous avons publié un flash sur le bilan et les perspectives du Green Deal et du Plan d’action pour la Finance Durable, dans la perspective des élections européennes, ainsi qu'un flash sur les raisons de notre upgrade à Best-in-class d'ASML. L'ensemble des résolutions soutenues par le Conseil d'Administration de TotalEnergies ont été approuvées lors de l’AG. VW a confirmé son projet de nouvelle voiture BEV d'ici à 2027 et a indiqué qu'il la développerait seul. S...
GenSight Biologics nomme William Monteith à son Conseil d’administrati...
PARIS--(BUSINESS WIRE)-- Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible au PEA-PME) (Paris:SIGHT), société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les maladies rétiniennes neurodégénératives et les troubles du système nerveux central, annonce la nomination de William Monteith à son Conseil d’administration. M. Monteith a pris ses fonctions d’Administrateur indépendant après approbation par les membres actuels du Conseil lors de la réunion qui s’est tenue le 29 mai 2024. « Je suis...
Transgene - First Patient Enrolled in Phase II Part of Randomized Phas...
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer Patient screening and enrollment initiated for the Phase II part of the international randomized Phase I/II trial with an overall sample size of approximately 80 patients. Last patient enrollment for Phase II part expected in Q4 2025. Strasbourg, France, June 3, 2024, 7:30 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announces that the first p...
BGHL (EUR): NAV(s)
BGHL (EUR): NAV(s) BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 31 May 2024. Estimated NAV Euro Shares Sterling Shares Estimated NAV € 28.0156 £ 25.1139 Estimated MTD return 1.19 % 1.29 % Estimated YTD return 1.70 % 2.21 % Estimated ITD return 180.16 % 151.14 % NAV and returns are calculated net of management and performance fees Ma...
BGHL (GBP): NAV(s)
BGHL (GBP): NAV(s) BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 31 May 2024. Estimated NAV Euro Shares Sterling Shares Estimated NAV € 28.0156 £ 25.1139 Estimated MTD return 1.19 % 1.29 % Estimated YTD return 1.70 % 2.21 % Estimated ITD return 180.16 % 151.14 % NAV and returns are calculated net of management and performance fees Ma...
GenSight Biologics Appoints William Monteith to its Board of Directors
PARIS--(BUSINESS WIRE)-- Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible) (Paris:SIGHT), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the appointment of William Monteith to its Board of Directors. Mr. Monteith joined as an independent Director after existing Board members approved his nomination at the meeting on May 29, 2024. “I am excited by the opportunity to serve as an advisor and expert resource for the GenS...
Number of voting rights as of May 31, 2024
Number of voting rights as of May 31, 2024 Nicox SA Société anonyme with a registered capital of € 502,996.94 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois – 06410 BiotR.C.S. ANTIBES 403.942.642 On June 3rd, 2024, MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS (Article 223-16 of the General Regulation of the AMF) Market: Euronext Growth Paris ISIN Code: FR0013018124Website: As of May 31, 2024Total number of shares composing the share capital 50,299,694 Total theoretical number of...
Vallourec: Andre Lacerda Appointed Senior Vice President of South Amer...
Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities) Press release Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities) Meudon (France), June 3rd 2024 – Vallourec, a world leader in premium tubular solutions, announces the appointment of Andre Lacerda as Senior Vice President South America for the Tubes segment. In this capacity, he joins the Group's Executive Committee and will report to Bertrand Frischmann, Chief Operating Officer of the Americas. Andre Lacerda has extensive international experience with several worl...
BW Energy: Fixed Income Investor Meetings
BW Energy: Fixed Income Investor Meetings BW Energy: Fixed Income Investor Meetings BW Energy has engaged DNB Markets, a part of DNB Bank ASA and Pareto Securities AS as Joint Bookrunners to arrange a series of fixed income investor meetings. Subject to inter alia market conditions and acceptable terms, a new senior unsecured bond issue of USD 100 million with a tenor of five years may follow. The purpose of the bond issue is for general corporate purposes. For further information, please contact: Knut R. Sæthre, CFO BW Energy, or About BW Energy: BW Energy is a growth E&P...
BW Energy: Appraisal confirms material Hibiscus field reserve increase
BW Energy: Appraisal confirms material Hibiscus field reserve increase BW Energy: Appraisal confirms material Hibiscus field reserve increase Reference is made to the stock exchange notice by BW Energy on 20 May 2024 announcing a substantial oil discovery on the northern flank of the Hibiscus field. BW Energy has now concluded the drilling and the logging of the DHIBM-7P pilot well, confirming a substantial oil discovery with good reservoir quality and a material uplift to the Hibiscus area. The Company’s preliminary evaluation indicates an increase in Hibiscus gross recoverable reserves...
Divis Laboratories Ltd: 2 directors
Two Directors at Divis Laboratories Ltd sold 900 shares at between 4,415.000INR and 4,430.000INR. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.